Journal of Clinical Endocrinology & Metabolism, Vol 71, 360-369, Copyright © 1990 by Endocrine Society

ARTICLES

Neuroendocrine sources of chromogranin-A in normal man: clues from selective stimulation of endocrine glands

MA Takiyyuddin, JH Cervenka, MR Pandian, CA Stuenkel, HP Neumann and DT O'Connor
Department of Medicine, University of California, San Diego.

Chromogranin-A (CgA), as measured in the circulation by RIA, has emerged as a useful probe of exocytotic sympathoadrenal activity in man as well as of the presence and extent of neuroendocrine neoplasia. Here we studied, using a sensitive RIA, the distribution of CgA immunoreactivity in normal human neuroendocrine tissues. Furthermore, to investigate whether these normal tissue sources measurably contribute to plasma CgA, we measured plasma CgA, catecholamine, and other polypeptide hormone responses to selective stimuli of secretion at several sites within the neuroendocrine system. Immunoreactive CgA was ubiquitous in human neuroendocrine tissues, in rank order of concentration (micrograms per g wet wt): adrenal medulla greater than pituitary greater than pancreas greater than stomach greater than small intestine (jejunoileum) greater than brain (frontal cortex) greater than parathyroid greater than thyroid. Quantitatively, neuroendocrine tissues other than the adrenal medulla possessed only 0.04-25% of the immunoreactivity found in the adrenal medulla. Insulin-induced hypoglycemia, a potent stimulus of adrenomedullary secretion, resulted in 1.7- and 14-fold rises in plasma CgA and epinephrine, respectively. However, insulin-induced hypoglycemia failed to perturb plasma CgA in three bilaterally adrenalectomized patients, suggesting that the adrenal medulla is the source of plasma CgA elevation during hypoglycemia in normal subjects. Cell type-selective secretagogue stimulation of normal endocrine secretory cells other than the adrenal medulla (pituitary, pancreas, gut, thyroid, and parathyroid) induced measurable increments in the concentrations of the resident peptide hormones, but left plasma CgA unperturbed. Nonselective stimulation of a wide variety of endocrine secretory cells with pentagastrin elevated plasma CgA 1.4-fold. However, restriction of pentagastrin's targets by coinfusion of calcium abolished the effect on plasma CgA. Hence, within the normal human neuroendocrine system, only selective stimulation of the adrenal medulla is likely to elevate plasma CgA under physiological or pharmacological circumstances. This is consistent with our finding of the adrenal medulla as the quantitatively major normal neuroendocrine tissue source of CgA immunoreactivity.

This article has been cited by other articles:

				T. Borglum, J. F. Rehfeld, L. B. Drivsholm, and L. Hilsted Processing-Independent Quantitation of Chromogranin A in Plasma from Patients with Neuroendocrine Tumors and Small-Cell Lung Carcinomas Clin. Chem., March 1, 2007; 53(3): 438 - 446. [Abstract] [Full Text] [PDF]

				N. Kanamoto, T. Akamizu, T. Tagami, Y. Hataya, K. Moriyama, K. Takaya, H. Hosoda, M. Kojima, K. Kangawa, and K. Nakao Genomic Structure and Characterization of the 5'-Flanking Region of the Human Ghrelin Gene Endocrinology, September 1, 2004; 145(9): 4144 - 4153. [Abstract] [Full Text] [PDF]

				L. Taupenot, K. L. Harper, and D. T. O'Connor The Chromogranin-Secretogranin Family N. Engl. J. Med., March 20, 2003; 348(12): 1134 - 1149. [Full Text] [PDF]

				A. LASLOP and S. K. MAHATA Neuropeptides and Chromogranins: Session Overview Ann. N.Y. Acad. Sci., October 1, 2002; 971(1): 294 - 299. [Abstract] [Full Text] [PDF]

				W. J. CURRY, S. C. BARKATULLAH, A. N. JOHANSSON, J. G. QUINN, P. NORLEN, C. K. CONNOLLY, A. P. McCOLLUM, and C. M. McVICAR WE-14, a Chromogranin A-Derived Neuropeptide Ann. N.Y. Acad. Sci., October 1, 2002; 971(1): 311 - 316. [Abstract] [Full Text] [PDF]

				P. Florio, A. Mezzesimi, V. Turchetti, F. M. Severi, C. Ticconi, S. Forconi, and F. Petraglia High Levels of Human Chromogranin A in Umbilical Cord Plasma and Amniotic Fluid at Parturition Reproductive Sciences, January 1, 2002; 9(1): 32 - 36. [Abstract] [PDF]

				T. Borglum Jensen, L. Hilsted, and J. F. Rehfeld Library of Sequence-specific Radioimmunoassays for Human Chromogranin A Clin. Chem., April 1, 1999; 45(4): 549 - 560. [Abstract] [Full Text] [PDF]

				M. A. Takiyyuddin, R. J. Parmer, M. T. Kailasam, J. H. Cervenka, B. Kennedy, M. G. Ziegler, M.-C. Lin, J. Li, C. E. Grim, F. A. Wright, et al. Chromogranin A in Human Hypertension : Influence of Heredity Hypertension, July 1, 1995; 26(1): 213 - 220. [Abstract] [Full Text]